6月20日晚,美国《制药经理人》杂志重磅“2025 全球制药企业50强”榜单发布,时间对比以往稍晚了一些。该榜单根据处方药的销售业绩,对全球前50强生物制药公司进行排名,并记录它们的发展与衰退历程——从传统大型制药企业的老牌巨头,到生物技术领域的新兴挑战者,以及介于这两者之间的所有企业。按照2024年度处方药业务全球销售收入排名,今年的前十强公司依次是:强生创新制药、艾伯维、默沙东、罗氏制药、辉瑞...
Source Link6月20日晚,美国《制药经理人》杂志重磅“2025 全球制药企业50强”榜单发布,时间对比以往稍晚了一些。该榜单根据处方药的销售业绩,对全球前50强生物制药公司进行排名,并记录它们的发展与衰退历程——从传统大型制药企业的老牌巨头,到生物技术领域的新兴挑战者,以及介于这两者之间的所有企业。按照2024年度处方药业务全球销售收入排名,今年的前十强公司依次是:强生创新制药、艾伯维、默沙东、罗氏制药、辉瑞...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.